Authors

Latest:

Dr. Nguyen on the Efficacy of IS-002 for Robotic Prostatectomy in Prostate Cancer

Hao G. Nguyen MD, PhD, discusses the efficacy and safety of IS-002, a prostate-specific membrane antigen–targeting fluorophore, for image-guided surgery in patients with prostate cancer undergoing robotic prostatectomy.

Vivek K. Narayan, MD, MS

Latest:

Dr Narayan on the Evolving Treatment Paradigm in Metastatic Urothelial Carcinoma

Vivek K. Narayan, MD, MS, discusses potential avenues for treatment considerations in patients with metastatic urothelial carcinoma.

Jan Philipp Bewersdorf, MD

Latest:

Dr Bewersdorf on Ruxolitinib Plus Abemaciclib in Myelofibrosis

Jan Bewersdorf, MD, discusses the design of an ongoing phase 1 trial investigating ruxolitinib plus abemaciclib in patients with primary or secondary myelofibrosis.

Brandon S. Sheffield, MD

Latest:

Dr. Sheffield on the Economic Cost of Delaying of Treatment in NSCLC

Brandon S. Sheffield, MD, discusses the economic cost of delaying treatment while conducting biomarker testing in non–small cell lung cancer.

Lajos Pusztai, MD, PhD, Yale Cancer Center

Latest:

HR+ Breast Cancer: Role of RxPONDER Data in Clinical Practice

Lajos Pusztai, MD, PhD, and Priyanka Sharma, MD, share closing thoughts on additional data they hope to see from the RxPONDER trial, and using these data in clinical practice for the treatment of HR+ early breast cancer.

Hana Safah, MD

Latest:

Supportive Care and Medication Access in GvHD

Hana Safah, MD, and Corey Cutler, MD, MPH, conclude with clinical insights on addressing medication access and the supportive care needs of patients with GvHD.

Jen-Jane Liu, MD

Latest:

Dr Liu on the Use of PSMA PET to Inform Lymph Node Dissection in Prostate Cancer

Jen-Jane Liu, MD, discusses how prostate-specific membrane antigen PET imaging may help inform lymph node dissection in the localized disease setting for patients with prostate cancer.

Karamjeet Singh Sandhu, MD

Latest:

Dr Sandhu on a Pooled Analysis of the FELIX Trial in Relapsed/Refractory B-ALL

Karamjeet Singh Sandhu, MD, discusses outcomes from a pooled analysis of the FELIX study in relapsed/refractory B-cell acute lymphoblastic leukemia.

Anwaar Saeed, MD

Latest:

Dr Saeed on the Rationale for Evaluating the Combination of Zanzalintinib Plus Atezolizumab vs Regorafenib in mCRC

Anwar Saeed, MD, discusses the rationale behind the STELLAR-303 trial evaluating zanzalintinib plus atezolizumab vs regorafenib in pretreated mCRC

Jordan B. Milner, MD

Latest:

Dr. Milner on Hematopoietic Stem Cell Transplant in Aplastic Anemia

Jordan B. Milner, MD, discusses findings from a study evaluating the use of hematopoietic stem cell transplant up front or as salvage therapy after unsuccessful immunosuppressive therapy in pediatric patients with severe aplastic anemia.

A. Oliver Sartor, MD, Tulane Cancer Center

Latest:

Rapid Readouts: Results from the Phase 3 VISION Study

A. Oliver Sartor, MD, presents data from the American Society of Clinical Oncology 2021 annual meeting from the VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.

Mendel Goldfinger, MD

Latest:

CAR T-Cell Therapy for Multiple Myeloma: Eliminating Disparities Through Accountability

Although the first FDA approval for CAR T-cell therapy in multiple myeloma was 2 years ago, unfortunately, the treatment remains out of reach for too many patients.

Sheela Rao, MBBS, MD, FRCP

Sheela Rao, MBBS, MD, FRCP, consultant medical oncologist in the Gastrointestinal Unity at the Royal Marsden Hospital in the United Kingdom.

Latest:

Dr Rao on the Current Treatment Landscape in Localized Anal Cancer

Sheela Rao, MBBS, MD, FRCP, highlights the current treatment landscape in the localized anal cancer setting for anal cancer Awareness Day, March 21.

Kelly E. McCann, MD, PhD

Kelly E. McCann, MD, PhD, is an assistant professor and breast medical oncologist at UCLA.

Latest:

Exciting New Data for TNBC Therapies

Panelists discuss how new trial results from ASCENT-03 and TROPION-Breast02 are shaping next-generation TNBC therapies.

Kathleen Lutz, RN, NP-BC WH

Latest:

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.

Naval G. Daver, MD

Naval G. Daver, MD, is a professor and director of the Leukemia Research Alliance Program in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.

Latest:

Dr Daver on Persisting Gaps in the Treatment of Relapsed/Refractory Higher-Risk MDS

Naval G. Daver, MD, discusses persisting gaps in the treatment of patients with relapsed/refractory higher-risk myelodysplastic syndromes.

Christine Ann Garcia, MD, MPH

Christine Ann Garcia, MD, MPH, is an assistant professor of medicine, the director of the Hematology and Oncology Fellowship Program, the director of Oncology Quality and Patient Safety, and the chair of the Oncology Quality and Patient Safety Committee at Weill Cornell Medical College, as well as an assistant attending physician at NewYork-Presbyterian Hospital.

Sravanti Rangaraju, MD

Latest:

Student Loan Debt, Immigration Status Often Drive Career Decisions for Fellows

Investigators from Indiana University decided to study some of the factors influencing career plans for physicians, focusing on current fellows and recent graduates of the hematology and medical oncology specialty in the United States.

David Ziegler, MD, PhD

Latest:

Dr Ziegler on Tovorafenib in Pediatric Low-Grade Glioma

David Ziegler, MD, PhD, discusses findings from the phase 2 FIREFLY-1 trial of tovorafenib in pediatric patients with low-grade glioma.

Chenyang Zhan, MD, PhD

Chenyang Zhan, MD, PhD, is an interventional radiologist at Memorial Sloan Kettering Cancer Center in New York, New York.

Latest:

Key Areas of Future Research in Advanced Melanoma

Michael A. Postow, MD, and Chenyang Zhan, MD, PhD, discuss ongoing research to watch in advanced melanoma.